Consolidated Statement of Operations - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Apr. 30, 2020	Apr. 30, 2019
Details
Revenues	$ 3,178,742	$ 3,634,124	$ 7,404,058	$ 7,290,248
Cost of expenses:
Cost of revenues	2,421,113	2,036,347	4,707,180	4,068,766
Research and development expenses	103,394	139,318	215,697	283,273
Selling, general, and administrative expenses	2,292,416	2,422,361	4,460,766	4,668,259
Impairment charges	9,874,281	0	9,874,281	0
Operating Expenses	14,691,204	4,598,026	19,257,924	9,020,298
Loss from operations	(11,512,462)	(963,902)	(11,853,866)	(1,730,050)
Interest expense - related party	218,629	167,765	428,915	335,684
Loss before income taxes	(11,731,091)	(1,131,667)	(12,282,781)	(2,065,734)
Provision for income taxes	0	0	31,560	0
Net loss	$ (11,731,091)	$ (1,131,667)	$ (12,314,341)	$ (2,065,734)
Net loss per common share - basic	$ (1.52)	$ (0.15)	$ (1.60)	$ (0.27)
Net loss per common share - diluted	$ (1.52)	$ (0.15)	$ (1.60)	$ (0.27)
Weighted average number of common shares outstanding - basic	7,712,091	7,696,091	7,709,014	7,696,091
Weighted average number of common shares outstanding - diluted	7,712,091	7,696,091	7,709,014	7,696,091